Nasdaq TradeTalks: Pharma’s Untapped Profit Source
HealthPrize CEO Tom Kottler recently spoke with Jill Malandrino, host of Nasdaq’s Trade Talks, about why pharma should look to medication adherence as its new profit source. Watch the video from Nasdaq TV below:
Boehringer Ingelheim developed an adherence and engagement program for a daily respiratory inhaler, resulting in an increase in medication adherence of 2.8 fills over the program's initial period.
Find out how behavioral economics can help improve patient adherence in this article that details behavioral economics' power in engaging and motivating patients.